WallStreetZenWallStreetZen

NASDAQ: ACXP
Acurx Pharmaceuticals Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$0.37-0.02 (-5.13%)
Updated Apr 17, 2025
ACXP Price
$0.37
Fair Value Price
$0.23
Market Cap
$8.22M
52 Week Low
$0.30
52 Week High
$3.33
P/E
-0.43x
P/B
13.37x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$14.10M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
5.27
Operating Cash Flow
-$10M
Beta
0.6
Next Earnings
May 13, 2025
Ex-Dividend
N/A
Next Dividend
N/A

ACXP Overview

Acurx Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing antibiotics to treat bacterial infections. Its lead candidate is ibezapolstat to treat patients with clostridium difficile infections. Acurx is also developing ACX-375C, a treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals was incorporated in 2017 and is headquartered in Staten Island, NY.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ACXP's potential to beat the market

View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
ACXP
RankedUnranked of 463

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Protalix Biotherapeutics (PLX)
$2.61A
Aurinia Pharmaceuticals (AUPH)
$7.75A
Rigel Pharmaceuticals (RIGL)
$16.85A
View Top Biotech Stocks

Be the first to know about important ACXP news, forecast changes, insider trades & much more!

ACXP News

Overview

Due Diligence Score

–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ACXP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACXP ($0.37) is overvalued by 62.65% relative to our estimate of its Fair Value price of $0.23 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ACXP ($0.37) is not significantly undervalued (62.65%) relative to our estimate of its Fair Value price of $0.23 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ACXP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ACXP due diligence checks available for Premium users.

Valuation

ACXP fair value

Fair Value of ACXP stock based on Discounted Cash Flow (DCF)

Price
$0.37
Fair Value
$0.23
Overvalued by
61.34%
ACXP ($0.37) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ACXP ($0.37) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ACXP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACXP price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.43x
Industry
-177.72x
Market
27.98x

ACXP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
13.37x
Industry
4.05x
ACXP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACXP's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.8M
Profit Margin
0%
ACXP's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$3.9M
Liabilities
$3.2M
Debt to equity
5.27
ACXP's short-term assets ($3.86M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACXP's short-term assets ($3.86M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACXP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ACXP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.3M
Investing
$0.0
Financing
$194.5k
ACXP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACXP vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ACXP–$8.22M-3.12%-0.43x13.37x
APRE–$8.24M-2.41%-0.64x0.43x
PMCB–$8.17M+3.48%1.61x0.20x
DWTXF$8.16M+14.48%-0.34x-0.81x
CTXRF$8.32M-2.12%-0.17x0.13x
View Top Biotech Stocks

Acurx Pharmaceuticals Stock FAQ

What is Acurx Pharmaceuticals's quote symbol?

(NASDAQ: ACXP) Acurx Pharmaceuticals trades on the NASDAQ under the ticker symbol ACXP. Acurx Pharmaceuticals stock quotes can also be displayed as NASDAQ: ACXP.

If you're new to stock investing, here's how to buy Acurx Pharmaceuticals stock.

What is the 52 week high and low for Acurx Pharmaceuticals (NASDAQ: ACXP)?

(NASDAQ: ACXP) Acurx Pharmaceuticals's 52-week high was $3.33, and its 52-week low was $0.30. It is currently -88.78% from its 52-week high and 24.33% from its 52-week low.

How much is Acurx Pharmaceuticals stock worth today?

(NASDAQ: ACXP) Acurx Pharmaceuticals currently has 22,042,511 outstanding shares. With Acurx Pharmaceuticals stock trading at $0.37 per share, the total value of Acurx Pharmaceuticals stock (market capitalization) is $8.22M.

Acurx Pharmaceuticals stock was originally listed at a price of $7.89 in Jun 25, 2021. If you had invested in Acurx Pharmaceuticals stock at $7.89, your return over the last 3 years would have been -95.27%, for an annualized return of -63.84% (not including any dividends or dividend reinvestments).

How much is Acurx Pharmaceuticals's stock price per share?

(NASDAQ: ACXP) Acurx Pharmaceuticals stock price per share is $0.37 today (as of Apr 17, 2025).

What is Acurx Pharmaceuticals's Market Cap?

(NASDAQ: ACXP) Acurx Pharmaceuticals's market cap is $8.22M, as of Apr 21, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Acurx Pharmaceuticals's market cap is calculated by multiplying ACXP's current stock price of $0.37 by ACXP's total outstanding shares of 22,042,511.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.